AVANCE (AVANCE) Fair Value & Analysis
IN · Market cap ₹2.0B
Fair value as of: Jul 5, 2026
From 10 valuation models · updated today
Price vs Fair Value (12 months)
12‑month range ₹0.8600 – ₹3.15 · fair‑value band ₹1.14 – ₹1.42 · the ₹1.00 price screens below the ₹1.14 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
AVANCE (AVANCE) currently trades at ₹1.00, while our model-based Fair Value estimate is ₹1.14 — implying the stock looks roughly 14.0% undervalued today. We read business quality at 41/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, AVANCE generated revenue of ₹1.6B at a net margin of 8.3%. Revenue declined 68.7% year over year. It earns a return on equity of 3.4%. Net debt stands at ₹1.6B. Fundamentals as of Jul 5, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
AVANCE reported revenue of ₹1.6B in FY2026 versus ₹115M in FY2022, a compound +92.8%/yr. Reported net income was ₹132M in FY2026.
Is AVANCE fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is AVANCE (AVANCE) undervalued?
What is the fair value of AVANCE?
What is the quality score of AVANCE?
What is the revenue of AVANCE (AVANCE)?
What is the net profit margin of AVANCE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.